Phase 2

Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma

Sponsor:

Abramson Cancer Center at Penn Medicine

Code:

NCT02153229

Conditions

Epitheliod Malignant Pleural Mesothelioma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Photodynamic Therapy

Radical Pleurectomy

Chemotherapy

Photofrin 2.0 mg/kg

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information